Evidence map›Paper›PMID 38031352›Full record

ArticleJournal of cutaneous pathology2024

Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.

Gregory S Phillips, Stephanie Mengden-Koon, Julie Dhossche, Philip E LeBoit, Alisa M Goldstein, Ina Lee, Mark Raffeld, Antonios Papanicolau-Sengos, Michael R Sargen, Jina Chung

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of cutaneous pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Gregory S PhillipsDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0009-0000-9028-2504
Stephanie Mengden-KoonDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
Julie DhosscheDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
Philip E LeBoitDermatopathology and Oral Pathology Service, Department of Pathology, University of California San Francisco, San Francisco, California, USA.
Alisa M GoldsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.
Ina LeeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Mark RaffeldLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Antonios Papanicolau-SengosLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Michael R SargenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.
Jina ChungDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0001-9140-7815
National Institutes of Health · USOregon Health & Science University · USUniversity of California, San Francisco · US

Funding

Family Studies ZIACP004410 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$56.1M
Center for Cancer Research, National Cancer Institute, National Institutes of HealthDivision of Cancer Epidemiology and Genetics, National Cancer InstituteIntramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

A host of signature genetic alterations have been demonstrated in Spitz neoplasms, most notably fusions of kinase genes (including BRAF, ALK, ROS1, NTRK1, NTRK3, RET, MET, MAP3K8) or variants in HRAS. While there are multiple reports of rearrangements involving NTRK1 and NTRK3 in Spitz tumors, there are very few reports of NTRK2-rearranged Spitz nevi in the literature. This report presents an NTRK2-rearranged atypical Spitz tumor with spindled cell features. The patient was a 6-year-old female with a growing pigmented papule on the back. Histopathological evaluation revealed an asymmetric, biphasic, compound proliferation of melanocytes featuring an epithelioid cell population arranged as variably sized nests and single cells along the basal layer with extension down adnexa, as well as a population of spindled melanocytes with desmoplastic features and loss of Melan-A expression in the dermis. There was partial loss of p16 expression in the epidermal component and diffuse loss in the dermal component. Immunohistochemistry for PRAME, ALK, NTRK1, HRAS Q61R, p53, and BRAF V600E were negative. A SQSTM1::NTRK2 fusion was identified by RNA sequencing. No TERT promoter hotspot variants were detected. This case report expands the known histopathologic spectrum of genetic alterations in Spitz neoplasms.

Indexed as

Nevus, Epithelioid and Spindle CellSkin NeoplasmsAntigens, NeoplasmChildFemaleHumansProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins B-rafReceptor Protein-Tyrosine KinasesSequestosome-1 ProteinAntigens, NeoplasmPRAME protein, humanProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins B-rafReceptor Protein-Tyrosine KinasesSequestosome-1 ProteinSQSTM1 protein, humanATMatypical Spitz tumorNTRK2SQSTM1

Identifiers

PMID38031352
PMCPMC11484923
OpenAlexW4389179948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.